Since 1995, NI Research has been the leading resource for independent information and analysis regarding the next generation of neurotherapeutics. It is to NI Research publications that the pharma industry and investment professionals turn for objective appraisals of scientific programs, companies seeking to bring them forward, and for consultation regarding strategy and licensing. NI Research emphasizes independence and objectivity: No advertising or sponsorships are accepted.

 NIR's quarterly publication, NeuroPerspective, is utilized by pharmaceutical companies and venture capital professionals around the world. NIR has also published  NeuroLicensing and the Private CNS Company Review. NIR  provides consulting services to pharmaceutical companies, ranging from the largest of major pharma companies to small startups, and to venture capital/private equity group assessing CNS investment opportunities.

NI Research

Org chart

Teams

Offices